Analysis of Linear Growth in Children after Living-related Liver Transplantation.
- Author:
Sun Hee RIM
1
;
Hye Jin YUN
;
Young Mee SUH
;
Bo Hwa CHOI
;
Kyung Mo KIM
;
Young Joo LEE
;
Sung Gyu LEE
Author Information
1. Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Living-related liver transplantation;
Child;
Linear growth
- MeSH:
Adolescent;
Child*;
Chungcheongnam-do;
Follow-Up Studies;
Hepatitis;
Humans;
Immunosuppressive Agents;
Liver Cirrhosis;
Liver Diseases;
Liver Transplantation*;
Liver*;
Lymphoproliferative Disorders;
Medical Records
- From:Korean Journal of Pediatric Gastroenterology and Nutrition
2001;4(1):63-70
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The aim of this study is to evaluate the effective role of living-related liver transplantation (LRLT) on posttransplant linear growth in children. METHODS: Thirty six children were enrolled who received LRLT at Asan Medical Center from December, 1994 to February, 1999 and showed more than one-year postoperative survival. Mean height standard deviation score (zH) was analyzed according to medical records including heights during pretransplant and posttransplant follow-up periods. RESULTS: zH of total children showed significant linear growth after LRLT from -1.58 to 0.33 at 24 posttransplant month (p<0.05). zH in children under 6 years of age, to exclude the effect of adolescent linear growth spurt, showed increment in height (p<0.05). Linear growth of children with liver cirrhosis improved and that with fulminant hepatitis was matained same. While stunted children (mean zH=-2.30) achieved good catch-up growth after transplantation, children with normal growth remained same. Children with significant hepatic dysfunction after LRLT such as chronic rejection or posttransplant lymphoproliferative disorder showed retarded posttrasplant linear growth. There was no statistical difference according to the type of immunosuppressants. CONCLUSION: LRLT resulted in adequate or catch-up linear growth in children with acute, chronic and metabolic liver disease. Successful LRLT suggested to be a promising option not only in long term survival but also in normal linear growth.
